Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-28T11:58:34.156Z Has data issue: false hasContentIssue false
  • English
  • Français

The effectiveness of the combination fluoxetine-naltrexone in bulimia nervosa

Published online by Cambridge University Press:  16 April 2020

I Maremmani ,
G Marini ,
P Castrogiovanni  and
J Deltito
I Maremmani
Affiliation:
Psychiatric Institute, University of Pisa, Via Roma 67, 56100Pisa
G Marini
Affiliation:
Psychiatric Institute, University of Pisa, Via Roma 67, 56100Pisa
P Castrogiovanni
Affiliation:
Psychiatric Clinic, University of Sienna, Sienna, Italy
J Deltito
Affiliation:
Anxiety and Mood Disorders Program, Cornell University, White Plains, NY, USA
Get access

Summary

Four patients with DSM-IV bulimia nervosa were treated in a crossover trial with naltrexone alone, fluoxetine alone, and a fluoxetine-naltrexone combination. Three patients presented a complete remission when treated with the fluoxetine-naltrexone combination.

Keywords

fluoxetinenaltrexonebulimia nervosacrossover trial
Type
Short communication
Information
European Psychiatry , Volume 11 , Issue 6 , 1996 , pp. 322 - 324
Copyright
Copyright © Elsevier, Paris 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Childs, ANaltrexone in organic bulimia: a preliminary report Brain Inj 1987 1/1 49–55CrossRefGoogle Scholar
Enas, JJ, Pope, HG, Levine, LRFluoxetine in bulimia nervosa: double-blind study142nd Ann Meet Am Psychiatr Assoc. San FranciscoAPA 1989Google Scholar
Freeman, CPL, Morris, JE, Cheshire, KEA double blind controlled trial of fluoxetine versus placebo for bulimia nervosa (abstr)3rd Int Conf Eating Disorders New York 1988Google Scholar
Goldbloom, DS, Kennedy, SHAdvised interaction of fluoxetine and cyproheptadine in two patients with bulimia nervosa J Clin Psychiatry 1991 52 261–262Google Scholar
Hollander, E, Mullen, LS, Carrasco, JR, De Caria, CM, Stein, DJSymptom relapse in bulimia nervosa and obsessive-compulsive disorder after treatment with serotonin antagonists J Clin Psychiatry 1992 53/1 28Google Scholar
Jonas, JM, Gold, MSNaltrexone reverses bulimic symptoms Lancet 1986 1 807CrossRefGoogle ScholarPubMed
Jonas, JM, Gold, MSThe use of opiate antagonists in treating bulimia: a study of low dose vs high dose naltrexone Psychiatry Res 1988 24/2 195–199CrossRefGoogle Scholar
Kaspers, S, Fuger, J, Moller, HJComparative efficacy of antide-pressants Drugs 1992 43suppl 2 11–23CrossRefGoogle Scholar
Maremmani, I, Zolesi, O, Daini, L, Castrogiovanni, P, Tagliamonte, AFluoxetine improves outcome in addicted patients treated with opioid antagonists Am J Addictions 1995 4/3 267–271Google Scholar
Mitchell, JE, Groat, RA placebo controlled, double-blind trial of amitriptyline in bulimia J Clin Psychopharmacol 1984 4 186–193CrossRefGoogle ScholarPubMed
Montgomery, SANew antidepressants and 5-HT uptake inhibitors Acta Psychiatr Scand 1989 80/350 (suppl) 107–116CrossRefGoogle Scholar
Morley, JEAn approach to the development of drugs for appetite disorders Neuropsychobiology 1989 21/1 22–30Google Scholar
Orsulak, PJ, Waller, DAntidepressant drugs: additional clinical cases J Fam Prac 1989 28/2 209–216Google Scholar
Solyom, L, Solyom, C, Ledwidge, CThe fluoxetine treatment of low-weight, chronic bulimia nervosa J Clin Psychopharmacol 1990 10/6 421–425CrossRefGoogle Scholar
Spigset, OTherapeutic appliance of drugs which act on serotonergic receptors Tidsskr Nor Laegeforen 1992 112/13 1700–1704Google Scholar
Submit a response

Comments

No Comments have been published for this article.